Evidence map›Paper›PMID 26687759›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

Lin28A enhances chemosensitivity of colon cancer cells to 5-FU by promoting apoptosis in a let-7 independent manner.

Tianzhen Wang, Peng Han, Yan He, Ci Zhao, Guangyu Wang, Weiwei Yang, Ming Shan, Yuanyuan Zhu, Chao Yang, Mingjiao Weng and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. MicroRNA Biogenesis Pathway Genes Are Deregulated in Colorectal Cancer.International journal of molecular sciences · 2019
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Tianzhen WangDepartment of Pathology, Harbin Medical University, Harbin, China.
Peng HanDepartment of Colorectal Surgery, The Affiliated Tumor Hospital of Harbin Medical University, Harbin, China.
Yan HeDepartment of Pathology, Harbin Medical University, Harbin, China.
Ci ZhaoDepartment of Gastrointestinal Medical Oncology, The Affiliated Tumor Hospital of Harbin Medical University, Harbin, China.
Guangyu WangDepartment of Gastrointestinal Medical Oncology, The Affiliated Tumor Hospital of Harbin Medical University, Harbin, China.
Weiwei YangDepartment of Pathology, Harbin Medical University, Harbin, China.
Ming ShanDepartment of Breast Surgery, The Affiliated Tumor Hospital of Harbin Medical University, Harbin, China.
Yuanyuan ZhuDepartment of Gastrointestinal Medical Oncology, The Affiliated Tumor Hospital of Harbin Medical University, Harbin, China.
Chao YangDepartment of Pathology, Harbin Medical University, Harbin, China.
Mingjiao WengDepartment of Pathology, Harbin Medical University, Harbin, China.
Di WuDepartment of Obstetrics and Gynecology, First Affiliated Hospital of Harbin Medical University, Harbin, China.
Lin GaoCenter for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin, China.
Xiaoming JinDepartment of Pathology, Harbin Medical University, Harbin, China.
Yunwei WeiDepartment of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
BinBin CuiDepartment of Colorectal Surgery, The Affiliated Tumor Hospital of Harbin Medical University, Harbin, China. 13351112888@163.com.
Guomin ShenDepartment of Medical Genetics, Medical College, Henan University of Science and Technology, Luoyang, China. shenba433@163.com.
Xiaobo LiDepartment of Pathology, Harbin Medical University, Harbin, China. lixiaobo@ems.hrbmu.edu.cn.ORCID http://orcid.org/0000-0003-1037-3903

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA-binding protein Lin28A is frequently over-expressed in human malignant tumors and is associated with tumor advance and poor prognosis. However, the expression pattern and functions of Lin28A in colon cancer are unknown. In this study, we detected the expression of Lin28A in colon cancer patients and tested the effect of Lin28A on the chemotherapeutic sensitivity of colon cancer cells to 5-fluorouracil (5-FU). As expected, we showed that Lin28A is up-regulated in 73.3 % of colon cancer patients. However, to our surprise, we found that oncogenic protein Lin28A-enforced expression in colon cancer cells enhanced the chemosensitivity of cancer cells to 5-FU via promoting the cell apoptosis. Further mechanisms study revealed that the effect of Lin28A increasing chemosensitivity of cancer cells is in a let-7 independent manner, but which is associated with decreasing the expression of DNA damage repair protein H2AX. Conclusively, here we reported an unexpected function of Lin28A, which may shed lights on fully understanding the physiological and pathological roles of this oncogene.

Indexed as

AdenocarcinomaAdultAgedAntimetabolites, AntineoplasticApoptosisColonic NeoplasmsDNA RepairDrug Resistance, NeoplasmFemaleFluorouracilHCT116 CellsHistonesHumansMaleMicroRNAsMiddle AgedAntimetabolites, AntineoplasticFluorouracilH2AX protein, humanHistonesLIN28B protein, humanMicroRNAsmirnlet7 microRNA, humanNeoplasm ProteinsRecombinant Fusion ProteinsRNA-Binding ProteinsRNA, NeoplasmApoptosisChemosensitivityColon cancerH2AXLin28A

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.